NASDAQ · Biotechnology

VYGR (VYGR) Stock

$3.13 +4.33% NASDAQ: VYGR Healthcare

Valuation

MetricValue
Price$3.13
Market Cap$189.12M
P/E Ratio-1.75
P/B Ratio1.10
P/S Ratio5.79
EPS (TTM)$-2.04
52-Week High$5.55
52-Week Low$2.83
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-61.22%
ROA-47.62%
ROCE-67.35%
Gross Margin-330.00%
Operating Margin-330.00%
Net Margin-3.20%
Debt/Equity0.20
Current Ratio7.52

Annual Financials (USD)

Metric20212022202320242025
Revenue$37.0M$41.0M$250.0M$80.0M$40.0M
Operating Profit$-74.0M$-51.0M$122.0M$-83.0M$-132.0M
Net Profit$-71.0M$-46.0M$132.0M$-65.0M$-120.0M
EPS$-1.75$-1.21$2.97$-1.13$-2.04
Op Margin-196.8%-124.3%48.8%-104.1%-326.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$194.0M$159.0M$351.0M$393.0M$252.0M
Total Liabilities$99.0M$100.0M$115.0M$93.0M$56.0M
Cash$117.0M$99.0M$69.0M$71.0M$65.0M
Borrowings$44.0M$23.0M$20.0M$44.0M$36.0M

Latest News

Voyager Therapeutics Expects to Start Early Alzheimer's Study in Adults in H2 MT Newswires · Jul 13, 2026 Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026 GlobeNewswire · Jul 13, 2026 Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s? Barrons.com · Jul 13, 2026 Cramer to a 23-Year-Old: Buy It, but It Might Take a ‘Lifetime’ to Make Money 24/7 Wall St. · Jul 2, 2026 Voyager Therapeutics (VYGR) is Amongst the Best Stocks Under $10, With More Than 50% Upside Insider Monkey · Jun 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-54.0M$-13.0M$78.0M$-15.0M$-132.0M
Investing Cash Flow$64.0M$-10.0M$-145.0M$-98.0M$123.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$13.0M$-18.0M$-30.0M$4.0M$-6.0M
Free Cash Flow$-55.0M$-15.0M$75.0M$-19.0M$-135.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-61.45%
Quick Ratio8.42
Interest Coverage—
Return 1Y-7.87%
Return 3Y-66.77%
Return 5Y-8.93%

Ownership

Insiders Held15.14%
Institutions Held56.31%
Institutions Float Held66.35%
Institutional HolderSharesReport Date
Blackrock Inc.5,568,3812026-03-31
Armistice Capital, LLC3,500,0002026-03-31
Millennium Management Llc3,428,5712026-03-31
Vestal Point Capital, LP3,002,9362026-03-31
Vanguard Capital Management LLC2,283,2532026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHV $6.66 +2.94% -4.63 $683.71M 0.00%
ALLO $1.95 +2.63% -2.17 $673.05M 0.00%
ARCT $6.26 +0.64% -2.93 $177.93M 0.00%
AVIR $4.75 +1.06% -2.13 $380.13M 0.00%
ENTA $12.61 -0.94% -6.04 $366.68M 0.00%

About VYGR

VYGR is led by CEO Alfred W. Sandrock Jr., publicly traded since 2015.

VYGR stock trades at $3.13 with a market capitalization of $189.12M. The stock is valued at a price-to-earnings (P/E) ratio of -1.75, price-to-book of 1.10, price-to-sales of 5.79. Over the past 52 weeks the stock has ranged between $2.83 and $5.55, and currently trades 43.6% below its 52-week high.

On profitability, VYGR generates a return on equity (ROE) of -61.22%, return on capital employed of -67.35%, an operating margin of -330.00%, a net profit margin of -3.20%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides